Skip to main content

Advertisement

SpringerLink
Log in

The association between CD14-260C/T polymorphism and malignant tumor risk: a meta-analysis of 5,603 participants

  • Research Article
  • Published:
Tumor Biology

Abstract

The CD14-260C/T polymorphism has been implicated to be in association with malignant tumor. However, a number of studies have reported inconclusive results. The aim of this study was to investigate the relationship of CD14-260C/T polymorphism and malignant tumor risk by meta-analysis. A search was performed in PubMed, Embase, the Chinese Journals Full-text Database (CNKI), and Wanfang databases up to August 2013. Odds ratio (OR) and 95 % confidence interval (95 % CI) were used to assess the association. Statistical analysis was calculated by STATA 11.0 software. The polymorphism was identified from 11 articles (12 case–control studies), involving 2,660 cases and 2,943 controls. Overall, no significant association between CD14-260C/T polymorphism and malignant tumor risk was found in the dominant model (TT + TC vs. CC: OR = 0.86, 95 % CI = 0.67–1.11). In the subgroup analysis by malignant tumor types, we found that the heterozygote model (TC vs. CC) might reduce the risk of malignant tumor, especially hematological malignance and prostate cancer (OR = 0.67, 95 % CI = 0.47–0.95), but not associated with gastrointestinal cancer susceptibility. In the subgroup analysis by ethnicity, no significant associations were found among different ethnicities. The study suggested that CD14-260C/T polymorphism might be a protective factor for hematological malignance and prostate tumor susceptibility but not an independent risk factor for gastrointestinal cancer susceptibility. To further evaluate the association between the polymorphism and malignant tumor susceptibility, more studies involving thousands of patients are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bredberg A. Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer. 2011;117(3):440–5.

    Article  PubMed  Google Scholar 

  2. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science. 1988;239(4839):497–500.

    Article  CAS  PubMed  Google Scholar 

  3. Hubacek JA, Pit’ha J, Škodová Z, Stanĕk V, Poledne R. C (−260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999;99(25):3218–20.

    Article  CAS  PubMed  Google Scholar 

  4. Zhang DE, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM, et al. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem. 1994;269(15):11425–34.

    CAS  PubMed  Google Scholar 

  5. Pugin J, Heumann D, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity. 1994;1(6):509–16.

    Article  CAS  PubMed  Google Scholar 

  6. Ziegler-Heitbrock H, Ulevitch R. CD14: cell surface receptor and differentiation marker. Immunol Today. 1993;14(3):121–5.

    Article  CAS  PubMed  Google Scholar 

  7. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol. 1995;154(10):5071–9.

    CAS  PubMed  Google Scholar 

  8. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol. 2002;3(7):667–72.

    CAS  PubMed  Google Scholar 

  9. Wu CY, Wang CJ, Tseng CC, Chen HP, Wu MS, Lin JT, et al. Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol. 2005;11(21):3197.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, et al. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor κB. Gastroenterology. 2003;124(4):983–92.

    Article  CAS  PubMed  Google Scholar 

  11. James BP, Sicheng W, Qiang PH, Marianne QJ. Secretion of matrix metalloproteinase‐9 by macrophages, in vitro, in response to Helicobacter pylori. FEMS Immunol Med Microbiol. 2005;45(2):159–69.

    Article  Google Scholar 

  12. Guo Q, Zhu J, Xia B. Polymorphism of CD14 gene but not the mutation of TLR4 gene is associated with colorectal cancer in Chinese patients. J Gastroenterol Hepatol. 2006;21(1):92–7.

    Article  CAS  PubMed  Google Scholar 

  13. Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83(4):334–42.

    Article  CAS  PubMed  Google Scholar 

  14. Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, et al. CD14-159C/T and TLR9-1237 T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev. 2009;18(2):117.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Tahara T, Shibata T, Hirata I, Nakano H, Arisawa T. Retracted article: CD14 promoter-159 polymorphism is associated with reduced risk of intestinal-type gastric cancer in a Japanese population. Dig Dis Sci. 2009;54(7):1508–12.

    Article  CAS  PubMed  Google Scholar 

  16. Min ZC, Mi YY, Shao N, Feng YH, Hua LX. Association between CD14-260 polymorphism and the risk of the prostate cancer. J Mod Urol. 2012;17(2):118–21.

    CAS  Google Scholar 

  17. Wu MS, Cheng TY, Shun CT, Lin MT, Chen LC, Lin JT. Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepato-Gastroenterology. 2005;53(71):807–10.

    Google Scholar 

  18. Yu X, Zhang C, Sun A, Jiang L, Zheng J, You Y, et al. Genetic variations in CD14 promoter and acute lymphoblastic leukemia susceptibility in a Chinese population. DNA Cell Biol. 2011;30(10):777–82.

    Article  CAS  PubMed  Google Scholar 

  19. Hao WY, Liang H. The influence of CD14-260 and-651 C/T polymorphism in H. pylori infection-related gastric carcinoma. Dissertation, Nankai University. 2010.

  20. Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, Cambray M, et al. Polymorphisms within inflammatory genes and colorectal cancer. J Negat Results Biomed. 2006;5(1):15.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, et al. Role of CD14 promoter polymorphisms in Helicobacter pylori infection-related gastric carcinoma. Clin Cancer Res. 2007;13(8):2362–8.

    Article  CAS  PubMed  Google Scholar 

  22. Castaño-Rodríguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case–control study and meta-analysis. PLoS ONE. 2013;8(4):e60327.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Zhu LX, Ho SC, Wong TK. Effectiveness of health education programs on exercise behavior among patients with heart disease: a systematic review and meta-analysis. J Evid Based Med. 2013;6(4):265–301.

  24. Zhan M, Xu T, Wu F. Sitagliptin in the treatment of type 2 diabetes: a meta-analysis. J Evid Based Med. 2012;5(3):154–65.

Download references

Conflict of interest

None

Author information

Authors and Affiliations

  1. West China School of Medicine/West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China

    Xiang Tong, Zhenzhen Li, Xiaowei Fu, Kai Zhou, Yao Wu & Hong Fan

  2. The Periodical Press of West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China

    Yonggang Zhang

  3. West China Hospital of Sichuan University, Guoxuexiang 37, Chengdu, Sichuan, 610041, China

    Hong Fan

Authors
  1. Xiang Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhenzhen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaowei Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kai Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yonggang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hong Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yonggang Zhang or Hong Fan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tong, X., Li, Z., Fu, X. et al. The association between CD14-260C/T polymorphism and malignant tumor risk: a meta-analysis of 5,603 participants. Tumor Biol. 35, 8707–8713 (2014). https://doi.org/10.1007/s13277-014-2040-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2040-8

Keywords

Search

Navigation